IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action

Acute myocardial infarction (AMI) and the heart failure (HF) which may follow are among the leading causes of death and disability worldwide. As such, new therapeutic interventions are still needed to protect the heart against acute ischemia/reperfusion injury to reduce myocardial infarct size and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lecour, Sandrine, Andreadou, Ioanna, Bøtker, Hans Erik, Davidson, Sean M., Heusch, Gerd, Ruiz-Meana, Marisol, Schulz, Rainer, Zuurbier, Coert J., Ferdinandy, Péter, Hausenloy, Derek J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Practical Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437922/
https://www.ncbi.nlm.nih.gov/pubmed/34515837
http://dx.doi.org/10.1007/s00395-021-00893-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437922/
https://www.ncbi.nlm.nih.gov/pubmed/34515837
http://dx.doi.org/10.1007/s00395-021-00893-5

Ejemplares similares